Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers

KENG-HSUEH LAN2018-09-102018-09-102004http://www.scopus.com/inward/record.url?eid=2-s2.0-6044223545&partnerID=MN8TOARShttp://scholars.lib.ntu.edu.tw/handle/123456789/306634[SDGs]SDG3Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancersjournal article10.1158/1078-0432.CCR-04-0112